Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert CofiledCriticalWarner Lambert Co
Priority to DO2004001000ApriorityCriticalpatent/DOP2004001000A/en
Publication of DOP2004001000ApublicationCriticalpatent/DOP2004001000A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Se describen ciertos ?-aminnoácidos que se unen a la subunidad alfa-2-delta (a2?) de un canal de calico. Estos compuestos y sus sales farmacéuticamente aceptables don útiles en el tratamiento de diversos trastornos psiquiátricos, del dolor y otros.Certain? -Amino acids that bind to the alpha-2-delta (a2?) Subunit of a calcium channel are described. These compounds and their pharmaceutically acceptable salts are useful in the treatment of various psychiatric, pain and other disorders.
DO2004001000A2004-09-232004-09-23
AMINO ACIDS WITH AFFINITY FOR PROTEIN
DOP2004001000A
(en)
PHARMACEUTICAL DOSAGE FORMS OF CONTROLLED RELEASE OF AN INHIBITOR OF THE PROTEIN OF TRANSFER OF ESTER OF CHOLESTERILE (CETPI), TO PROCEDURES OF USE AND PROCEDURES OF PREPARATION OF THE SAME.
Compounds derived from pyrazolic heterobicycles, inhibitors of thyroxine kinase protein activity; pharmaceutical composition comprising said compounds; and use of the compounds in the treatment of a hyperproliferative disease.
Compounds derived from 3-oxo-isoindoline-1-carboxamide, modulators of the sodium channel nav1,7; pharmaceutical composition comprising said compounds; and use in the treatment of a pain disorder.
Compounds derived from cyano-3-oxoisoindoline-1-carboxamide, modulators of the sodium channel nav1,7; pharmaceutical composition comprising said compounds; and use in the treatment of a pain disorder.